IL312041A - R-ketamine salts and methods of using them - Google Patents

R-ketamine salts and methods of using them

Info

Publication number
IL312041A
IL312041A IL312041A IL31204124A IL312041A IL 312041 A IL312041 A IL 312041A IL 312041 A IL312041 A IL 312041A IL 31204124 A IL31204124 A IL 31204124A IL 312041 A IL312041 A IL 312041A
Authority
IL
Israel
Prior art keywords
ketamine
salts
methods
ketamine salts
Prior art date
Application number
IL312041A
Other languages
English (en)
Hebrew (he)
Inventor
Mouhannad Jumaa
Terence Alfred Kelly
Original Assignee
Perception Neuroscience Inc
Mouhannad Jumaa
Terence Alfred Kelly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perception Neuroscience Inc, Mouhannad Jumaa, Terence Alfred Kelly filed Critical Perception Neuroscience Inc
Publication of IL312041A publication Critical patent/IL312041A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL312041A 2021-10-12 2022-10-12 R-ketamine salts and methods of using them IL312041A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163254878P 2021-10-12 2021-10-12
PCT/US2022/046412 WO2023064363A1 (en) 2021-10-12 2022-10-12 R-ketamine salts and methods of use thereof

Publications (1)

Publication Number Publication Date
IL312041A true IL312041A (en) 2024-06-01

Family

ID=84331621

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312041A IL312041A (en) 2021-10-12 2022-10-12 R-ketamine salts and methods of using them

Country Status (8)

Country Link
US (1) US20240336556A1 (cg-RX-API-DMAC10.html)
EP (1) EP4416126A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024539623A (cg-RX-API-DMAC10.html)
CN (1) CN118647595A (cg-RX-API-DMAC10.html)
CA (1) CA3234818A1 (cg-RX-API-DMAC10.html)
IL (1) IL312041A (cg-RX-API-DMAC10.html)
MX (1) MX2024004478A (cg-RX-API-DMAC10.html)
WO (1) WO2023064363A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3043785T3 (da) 2013-09-13 2021-11-15 Univ Chiba Nat Univ Corp Anvendelse af r-ketamin og salt deraf som lægemidler

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1444041A2 (en) 2001-09-21 2004-08-11 Solvias AG Sealing system with flow channels
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
DK3043785T3 (da) 2013-09-13 2021-11-15 Univ Chiba Nat Univ Corp Anvendelse af r-ketamin og salt deraf som lægemidler
WO2019065900A1 (ja) 2017-09-27 2019-04-04 国立大学法人千葉大学 神経変性疾患あるいは認知機能障害の予防または治療剤としてのr-ケタミンおよびその誘導体
WO2019160057A1 (ja) 2018-02-15 2019-08-22 国立大学法人千葉大学 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
CN118121577A (zh) 2018-05-04 2024-06-04 感知神经科学公司 治疗物质滥用的方法
US20220110889A1 (en) 2018-12-27 2022-04-14 National University Corporation Chiba University R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodevelopmental disorder
KR20220002905A (ko) * 2019-03-25 2022-01-07 더글라스 파머수티클스 리미티드 서방형 약학 제제
EP3968979B1 (en) * 2019-05-15 2026-07-01 Bexson Biomedical, Inc. KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
GB201912505D0 (en) * 2019-08-30 2019-10-16 Klaria Pharma Holding Ab Pharmaceutical formulation

Also Published As

Publication number Publication date
MX2024004478A (es) 2024-07-01
US20240336556A1 (en) 2024-10-10
CA3234818A1 (en) 2023-04-20
CN118647595A (zh) 2024-09-13
WO2023064363A9 (en) 2024-02-15
WO2023064363A1 (en) 2023-04-20
EP4416126A1 (en) 2024-08-21
JP2024539623A (ja) 2024-10-29

Similar Documents

Publication Publication Date Title
IL297625B2 (en) PI3K-alpha inhibitors and methods of using them
IL304680A (en) Urolithin history and methods of using them
IL287787B2 (en) Phenylaminopyrimidine amide as autophagy inhibitors and methods of using them
SG11202112171XA (en) Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
PT3911648T (pt) 6¿-[[(1s,3s)-3-[[5-(difluorometoxi)-2-pirimidinil]amino]ciclopentil]amino][1(2h),3¿-bipiridina]-2-ona como inibidor de pcsk9 e seus métodos de utilização
IL312348A (en) HIF-2ALPHA inhibitors and methods of using it
IL287973A (en) acss2 inhibitors and methods of their use
IL279475A (en) Actonucleotidase inhibitors and methods of using them
ZA202407941B (en) Arginase inhibitors and methods of use thereof
IL300040A (en) Crystalline forms of blomosodil and salts of blomosodil
IL299245A (en) LAIR-1 binding agents and methods of using them
IL280924A (en) Arginase inhibitors and methods of using them
GB2613900B (en) Novel compounds and methods of use thereof
IL277528B (en) Herbicidal compounds and methods of their use
IL312261A (en) Novovirus vaccine and methods of use
IL307752A (en) Intracardiac device and methods of use
IL280453B2 (en) History of benzenesulfonamide-phenyl-alkyloxy-alkyl acids and their use in therapy.
IL295228B2 (en) A method for the production of dalmofinol and its salts
GB202119051D0 (en) Wingsail and method of use
GB201811737D0 (en) Forceps and method of manufacture and use
HK40114491A (en) R-ketamine salts and methods of use thereof
SG11202011549RA (en) Topical formulations of dgat1 inhibitors and their methods of use
GB202004360D0 (en) Compounds and methods of use
IL290548A (en) Bacteria and methods of use thereof